Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer
Diseases of the Esophagus · 02.03.2026 · 39 (2)
DOI: 10.1093/dote/doag025 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diseases of the Esophagus, online erschienen am 30.03.2026. Verfasst von Koshiro Ishiyama und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Esophageal Surgery, National Cancer Center Hospital, Chuo-Ku, Tokyo, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophagectomy, Conversion to Open Surgery, Minimally Invasive Surgical Procedures. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Conversion surgery (CS) following induction therapy has emerged as a treatment option for patients with cT4b esophageal cancer previously considered unresectable. Minimally invasive approaches, including thoracoscopic and robot-assisted techniques, are increasingly applied in this setting. However, evidence comparing conversion minimally invasive esophagectomy (C-MIE) with conversion open esophagectomy (C-OE) remains limited. This single-center retrospective study included 66 patients with cT4b esophageal cancer who underwent CS after induction therapy between 2007 and 2023. Patients were classified into C-MIE (n = 41) or C-OE (n = 25) groups. Short-term outcomes, including operative time, blood loss, complications, and hospital stay, as well as long-term outcomes such as recurrence and survival, were compared. Prognostic factors were identified using multivariate Cox analysis. The C-MIE group showed markedly reduced intraoperative blood loss (79 vs. 470 mL, P < 0.001), lower incidence of anastomotic leakage (4.8 vs. 24%, P = 0.04), and shorter intensive care unit stay (3 vs. 4 days, P = 0.03) compared with the C-OE group. Three-year overall survival was higher in the C-MIE group (63.0 vs. 39.6%, P = 0.08), although not statistically significant. Multivariate analysis identified Clavien–Dindo grade ≥ IIIa (HR: 3.73, 95% CI: 1.81–7.67, P < 0.001) and ypStage ≥ III (HR: 3.51, 95% CI: 1.6–8.43, P = 0.001) as independent predictors of poorer survival. C-MIE showed a reduced risk but not significantly (HR: 0.79, 95% CI: 0.37–1.66; P = 0.537). C-MIE was associated with acceptable short-term outcomes and comparable long-term oncologic results to C-OE in patients with cT4b esophageal cancer responding to induction therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Esophageal Surgery, National Cancer Center Hospital, Chuo-Ku, Tokyo, Japan.
ORCID-Profile: Hiroyuki Daiko
Zitieren
APA
Ishiyama, K., Nozaki, R., Kakuta, R., Igaue, S., Akimoto, E., Utsunomiya, D., Kurita, D., Seto, Y., & Daiko, H. (2026). Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer. Diseases of the Esophagus, 39(2). https://doi.org/10.1093/dote/doag025
Vancouver
Ishiyama K, Nozaki R, Kakuta R, Igaue S, Akimoto E, Utsunomiya D, et al. Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer. Diseases of the Esophagus. 2026;39(2). doi:10.1093/dote/doag025
BibTeX
@article{Ishiyama2026,
author = {Ishiyama, Koshiro and Nozaki, Ryoko and Kakuta, Ryota and Igaue, Shota and Akimoto, Eigo and Utsunomiya, Daichi and Kurita, Daisuke and Seto, Yasuyuki and Daiko, Hiroyuki},
title = {Short- and long-term outcomes of conversion minimally invasive esophagectomy versus open approach following induction therapy in cT4b esophageal cancer},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {2},
doi = {10.1093/dote/doag025}
}
EUVIMED